Overview

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

Status:
Completed

Trial end date:
2011-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this clinical study is to evaluate and compare the efficacy and safety of Fimasartan (60mg / 120mg) with Candesartan(8mg) in patients with mild to moderate hypertension.

Phase:

Phase 3

Details

Lead Sponsor:

Boryung Pharmaceutical Co., Ltd

Collaborators:

Daegu Catholic University Medical Center
Dong-A medical center
Gyeongsang National University Hospital
Inje University
Keimyung University
Kosin University Gospel Hospital
Kyungpook National University
Kyungpook National University Hospital
Pusan National University Hospital
Pusan National University Yangsan Hospital
Ulsan University Hospital
Yeungnam University
Yeungnam University Hospital

Treatments:

Candesartan
Candesartan cilexetil